Assistant Professor
Washington University School of Medicine in St. Louis
Michael Slade is a third year fellow at the Washington University in Saint Louis School of Medicine/Barnes-Jewish Hospital Consortium. His current research interests are cellular immunotherapy for multiple myeloma and the role of measurable residual disease monitoring in treatment escalation/de-escalation.